September 28, 2023
Mad Hedge Biotech and Healthcare Letter September 28, 2023 Fiat Lux Featured Trade: (TIPPING THE SCALES) (NVO), (LLY), (PODD), (TNDM), (DXCM), (RMD), (INSP), (MDGL), (ISRG), (AKRO), (ETNB)
This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 3186 entries already.
Mad Hedge Biotech and Healthcare Letter September 28, 2023 Fiat Lux Featured Trade: (TIPPING THE SCALES) (NVO), (LLY), (PODD), (TNDM), (DXCM), (RMD), (INSP), (MDGL), (ISRG), (AKRO), (ETNB)
The pharmaceutical world is buzzing, and it’s all thanks to the groundbreaking obesity drugs from Novo Nordisk (NVO) and Eli Lilly (LLY). In my previous newsletter, I delved into the massive potential of these new treatments, and it sparked a flurry of discussions. So, this time, I want to peel back the layers and explore
Global Market Comments September 28, 2023 Fiat Lux Featured Trade: (THE MAD HEDGE TRADERS & INVESTORS SUMMIT VIDEOS ARE UP!) (THE MAD HEDGE DICTIONARY OF TRADING SLANG), (TESTIMONIAL)
Video replays from the September 12-13 confab are up. Listen to 15 speakers opine on the best strategies, tactics, and instruments to use in these volatile markets. It is a true smorgasbord of investment strategies. Find the best one that suits your own goals. The product discounts offered last week are still valid. Start, stop,
(MINATURE AI WILL BE BIG IN THE FUTURE) September 27, 2023 Hello everyone, We are living in the era of Artificial Intelligence (AI), and it will change our lives in many ways. Within AI there is currently a large focus on Tiny AI or Minature AI which aims to improve the sustainability of
Mad Hedge Biotech and Healthcare Letter September 26, 2023 Fiat Lux Featured Trade: (THE WEIGHT OF INNOVATION) (NVO), (LLY), (CI), (CVS)
In a world teetering on the brink of healthcare overload, the emergence of Novo Nordisk (NVO) and Eli Lilly's (LLY) revolutionary obesity drugs, Ozempic and Wegovy, is akin to sailing in uncharted waters. These drugs are heralded as the harbinger of unprecedented advancements in biotechnology and healthcare, but they also cast shadows of potential financial
Global Market Comments September 26, 2023 Fiat Lux Featured Trade: (I’M TAKING OFF FOR UKRAINE AND I NEED YOUR HELP) (DIAMONDS ARE STILL AN INVESTOR’S BEST FRIEND), (LAST CHANCE TO ATTEND THE FRIDAY, SEPTEMBER 29 ZERMATT, SWITZERLAND STRATEGY LUNCHEON)
I’ll be escorting American doctors to hospitals and orphanages in embattled Kiev that are rapidly running out of resources. I’ll also be delivering desperately needed supplies that will be handed out after I conduct careful due diligence. Included in my luggage will be a duffle bag of $10,000 in one-dollar bills. They don’t make change
If you forgot to buy your loved one a birthday present and spent a week sleeping on the sofa, eating canned food, and cleaning out the cat box, you now have a chance to redeem yourself. Diamond prices have just taken a steep plunge thanks to competition from the new artificial diamonds. A revolutionary new
Legal Disclaimer
There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.
